FDA clears stereotactic radiotherapy system for treating breast cancer
On Dec. 22, the U.S. Food and Drug Administration (FDA) cleared the GammaPod system, a new noninvasive stereotactic radiotherapy system for treating breast cancer.…
Web Exclusives
FDA updates Tasigna label to include stop treatment options
On Dec. 22, the U.S. Food and Drug Administration (FDA) updated the label of Tasigna to reflect that certain patients with a type of…
Effect of errors or adverse effects on NICU healthcare providers
A study in the Journal of Advanced Nursing reports that neonatal ICU healthcare providers who were involved in an error or adverse event incident…
Ginkgo biloba may reduce cognitive decline after stroke
Ginkgo biloba extract plus aspirin, compared to aspirin alone, is associated with less cognitive decline after stroke and doesn’t increase the incidence of vascular…
No special precautions needed for flu shots in people with egg allergies
An updated practice parameter from the Joint Task Force on Practice Parameters says that people with egg allergy should receive their yearly flu shot,…
Want to slow the aging process? Restrict your calories
A study shows that restricting caloric intake slows the aging process, according to an article in a special issue of Journals of Gerontology that…
FDA approves new treatment for eosinophilic granulomatosis with polyangiitis
On Dec. 12, the U.S. Food and Drug Administration (FDA) approved use of Nucala (mepolizumab) to treat adult patients with eosinophilic granulomatosis with polyangiitis…
Healthy eating improves children’s self-esteem
A healthy diet improves the self-esteem of children, according to a study in BMC Public Health. (more…)
Successful gene therapy for hemophilia
A single treatment with gene therapy normalized levels of Factor VIII in patients with hemophilia as long as 1 year after the infusion, according…
FDA approves first biosimilar for certain breast, stomach cancers
On Dec. 1, the U.S. Food and Drug Administration (FDA) approved Ogivri (trastuzumab-dkst) as a biosimilar to Herceptin (trastuzumab) for the treatment of patients…
FDA clears stereotactic radiotherapy system for treating breast cancer
On Dec. 22, the U.S. Food and Drug Administration (FDA) cleared the GammaPod system, a new noninvasive stereotactic radiotherapy system for treating…
FDA updates Tasigna label to include stop treatment options
On Dec. 22, the U.S. Food and Drug Administration (FDA) updated the label of Tasigna to reflect that certain patients with a…
Effect of errors or adverse effects on NICU healthcare providers
A study in the Journal of Advanced Nursing reports that neonatal ICU healthcare providers who were involved in an error or adverse…
Ginkgo biloba may reduce cognitive decline after stroke
Ginkgo biloba extract plus aspirin, compared to aspirin alone, is associated with less cognitive decline after stroke and doesn’t increase the incidence…
No special precautions needed for flu shots in people with egg allergies
An updated practice parameter from the Joint Task Force on Practice Parameters says that people with egg allergy should receive their yearly…
Want to slow the aging process? Restrict your calories
A study shows that restricting caloric intake slows the aging process, according to an article in a special issue of Journals of…
FDA approves new treatment for eosinophilic granulomatosis with polyangiitis
On Dec. 12, the U.S. Food and Drug Administration (FDA) approved use of Nucala (mepolizumab) to treat adult patients with eosinophilic granulomatosis…
Healthy eating improves children’s self-esteem
A healthy diet improves the self-esteem of children, according to a study in BMC Public Health. (more…)
Successful gene therapy for hemophilia
A single treatment with gene therapy normalized levels of Factor VIII in patients with hemophilia as long as 1 year after the…
FDA approves first biosimilar for certain breast, stomach cancers
On Dec. 1, the U.S. Food and Drug Administration (FDA) approved Ogivri (trastuzumab-dkst) as a biosimilar to Herceptin (trastuzumab) for the treatment…
Poll
Get your free access to the exclusive newsletter of American Nurse Journal and gain insights for your nursing practice.NurseLine Newsletter
*By submitting your e-mail, you are opting in to receiving information from Healthcom Media and Affiliates. The details, including your email address/mobile number, may be used to keep you informed about future products and services.